Key points are not available for this paper at this time.
How does once-weekly subcutaneous tirzepatide affect maintenance of weight loss in individuals with obesity or overweight?
Share your take
Add a clinician perspective alongside expert commentary.
Aronne et al. (Mon,) studied this question.